Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Society of Breast Surgeons (2005) Consensus Statement for Accelerated Partial Breast Irradiation. http://www.breastsurgeons.org/apbi.shtml
Arthur D (2003) Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer. J Surg Oncol 84:185–191
Arthur DW, Vicini FA (2004) MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 11:723–724
Arthur DW, Vicini FA, Kuske RR, et al (2002) Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 1:184–190
Arthur DW, Koo D, Zwicker RD, et al (2003) Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 56:681–689
Athas WF, Adams-Cameron M, Hunt WC, et al (2000) Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92:269–271
Baglan KL, Sharpe MB, Jaffray D, et al (2003) Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 55:302–311
Clark RM, McCulloch PB, Levine MN, et al (1992) Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683–689
Cuttino LW, Todor D, Arthur DW (2005) CT-guided multi-catheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity. Brachytherapy 4:10–17
Du X, Freeman JL, Freeman DH, et al (1999) Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol A Biol Sci Med Sci 54:M474–478
Faverly D, Holland R, Burgers L (1992) An original stereomicroscopic analysis of the mammary glandular tree. Virchows Arch A Pathol Anat Histopathol 421:115–119
Faverly DR, Burgers L, Bult P, et al (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11:193–198
Fentiman IS, Poole C, Tong D, et al (1996) Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A:608–611
Fisher B, Anderson S (1994) Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 18:63–69
Fisher B, Anderson S, Bryant J, et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
Fisher ER, Dignam J, Tan-Chiu E, et al (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86:429–438
Formenti SC, Rosenstein B, Skinner KA, et al (2002) T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients — pilot feasibility study. Radiology 222:171–178
Formenti SC, Truong MT, Goldberg JD, et al (2004) Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 60:493–504
Hahn CA, Marks LB, Chen DY, et al (2003) Breast conservation rates-barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys 55:1196–1199
Hebert-Croteau N, Brisson J, Latreille J, et al (1999) Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104–1113
Holland R, Veling SH, Mravunac M, et al (1985) Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979–990
Holli K, Saaristo R, Isola J, et al (2001) Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 84:164–169
Imamura H, Haga S, Shimizu T, et al (2000) Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 62:177–184
Keisch M, Vicini F, Kuske RR (2003a) Two-year outcome with the MammoSite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 60[Suppl 1]:s315
Keisch M, Vicini F, Kuske RR, et al (2003b) Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breastconserving therapy. Int J Radiat Oncol Biol Phys 55:289–293
King TA, Bolton JS, Kuske RR, et al (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180:299–304
Krishnan L, Jewell WR, Tawfik OW, et al (2001) Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7:91–96
Kuerer HM, Arthur DW, Haffty BG (2004) Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation. Cancer 100:2269–2280
Kuske RR Jr (1999) Breast brachytherapy. Hematol Oncol Clin North Am 13:543–558, vi–vii
Kuske RR, Bolton JS (1995) A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma (publication no. 1055). Radiation Therapy Oncology Group
Kuske RR, Winter K, Arthur D, et al (2002) A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of Radiation Therapy Oncology Group 95-17 (abstract). Int J Radiat Oncol Biol Phys 54(2 Suppl)
Kuske RR, Winter K, Arthur DW, et al (2004) A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 9517 (abstract 565). Proc Am Soc Clin Oncol 23
Lawenda BD, Taghian AG, Kachnic LA, et al (2003) Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56:671–680
Magee B, Swindell R, Harris M, et al (1996) Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol 39:223–227
Morrow M (2002) Rational local therapy for breast cancer. N Engl J Med 347:1270–1271
Nattinger AB, Hoffmann RG, Kneusel RT, et al (2000) Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356:1148–1153
NIH Consensus Development Conference (1990) Treatment of early-stage breast cancer. Consensus statement. Vol 8. June 18–21. Bethesda, MD, pp 1–9
Ohtake T, Abe R, Kimijima I, et al (1995) Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 76:32–45
Perera F, Yu E, Engel J, et al (2003) Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys 57:1239–1246
Polgar C, Sulyok Z, Fodor J, et al (2002) Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I–II study and initial findings of a randomized phase III trial. J Surg Oncol 80:121–128; discussion 129
Polgar C, Strnad V, Major T (2005) Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 15:116–122
Recht A, Houlihan MJ (1995) Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review. Ann Surg 222:9–18
Ribeiro GG, Magee B, Swindell R, et al (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5:278–283
Silverstein MJ (2000) Current management of noninvasive (in situ) breast cancer. Adv Surg 34:17–41
Strnad V, Ott O, Potter R, et al (2004) Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 3:115–119
Uppsala-Orebro Breast Cancer Study Group (1990) Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 82:277–282
Vaidya JS, Baum M, Tobias JS, et al (2001a) Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12:1075–1080
Vaidya JS, Tobias JS, Baum M, et al (2001b) Targeted intra-operative radiotherapy (Targit) for breast cancer: a randomized trial. Radiology [Suppl] 221:234
Vaidya JS, Tobias JS, Baum M, et al (2004) Intraoperative radiotherapy for breast cancer. Lancet Oncol 5:165–173
Veronesi U, Marubini E, Mariani L, et al (2001a) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:997–1003
Veronesi U, Orecchia R, Luini A, et al (2001b) A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37:2178–2183
Veronesi U, Cascinelli N, Mariani L, et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232
Veronesi U, Gatti G, Luini A, et al (2003) Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 138:1253–1256
Vicini FA, Arthur DW, Wazer DE (2002) Inconsistency, perspective, double talk, and false virtue. Brachytherapy 1:181–183
Vicini F, Arthur D, Polgar C, et al (2003a) Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys 57:1210–1213
Vicini FA, Kestin L, Chen P, et al (2003b) Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95:1205–1210
Vicini FA, Remouchamps V, Wallace M, et al (2003c) Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57:1247–1253
Wazer DE, Lowther D, Boyle T, et al (2001) Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50:107–111
Wazer D, Berle L, Graham R, et al (2002) Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53:889–897
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Arthur, D.W., Vicini, F.A., Wazer, D.E. (2006). Who is a Candidate for Accelerated Partial Breast Irradiation?. In: Wazer, D.E., Arthur, D.W., Vicini, F.A. (eds) Accelerated Partial Breast Irradiation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28203-3_2
Download citation
DOI: https://doi.org/10.1007/3-540-28203-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28202-0
Online ISBN: 978-3-540-28203-7
eBook Packages: MedicineMedicine (R0)